June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Polydopamine-coated and polyethylene glycol-impregnated corneas as tissue carriers for the Boston Keratoprosthesis
Author Affiliations & Notes
  • Sara Bozorg
    Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, MA
  • Kyung Jae Jeong
    Department of Anesthesiology, Division of Critical Care Medicine, Children's Hospital Boston, Harvard Medical School, Boston, MA
  • Samer Arafat
    Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, MA
  • Daniel Kohane
    Department of Anesthesiology, Division of Critical Care Medicine, Children's Hospital Boston, Harvard Medical School, Boston, MA
  • Claes Dohlman
    Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, MA
  • Footnotes
    Commercial Relationships Sara Bozorg, None; Kyung Jae Jeong, None; Samer Arafat, None; Daniel Kohane, None; Claes Dohlman, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 3478. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sara Bozorg, Kyung Jae Jeong, Samer Arafat, Daniel Kohane, Claes Dohlman; Polydopamine-coated and polyethylene glycol-impregnated corneas as tissue carriers for the Boston Keratoprosthesis. Invest. Ophthalmol. Vis. Sci. 2013;54(15):3478.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

To assess the integration and resistance to enzymatic degradation of porcine corneas impregnated with polyethylene glycol (PEG) or coated with polydopamine (PDA). The aim is to be able to use each modified tissue as a carrier for the Boston Keratoprosthesis.

 
Methods
 

Porcine corneas were lyophilized then rehydrated in either A) phosphate buffer saline (PBS), B) PEG solution (10% w/v) for one day then cross-linked with ultraviolet light, C) dopamine solution (2mg/mL in Tris buffer, pH 8.7) for one day, which polymerized (polydopamine, PDA) and coated the corneas. (n = 15 trephined buttons in each group). Integration of PEG hydrogel with cornea was evaluated by scanning electrom microscopy (SEM) as well as by measuring the compressive moduli. Resistance of the corneas to enzymatic degradation was evaluated by exposure to clostridium collagenase solution.

 
Results
 

Porcine corneas coated with PDA (Group C) showed significantly longer degradation time (>91h) than both control (5.0±0.7 h) and PEG treated groups (26±2.7 h). Mechanical strength testing revealed a difference between both PEG and PDA treated groups compared to the control group.

 
Conclusions
 

PEG- and PDA-modified corneas showed a markedly increased resistance to enzymatic degradation. The creation of a mussel inspired PDA coating on corneas may increase the strength and effectiveness of keratoprosthesis carrier tissue. In addition, PDA-modified corneas turn black which would reduce glare - a major problem in many keratoprosthesis cases (aniridia, etc.). Further in vivo studies are needed to assess the viability and safety of these modified corneas.

 
 
Polydopamine modified cornea as carrier for the Boston Keratoprosthesis.
 
Polydopamine modified cornea as carrier for the Boston Keratoprosthesis.
 
Keywords: 575 keratoprostheses • 480 cornea: basic science  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×